Acclinate
United States
- Birmingham, AL
- 08/05/2024
- Series A
- $17,000,000
Our vision is health equity through inclusive research. We help pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.
- Industry Biotechnology
- Website https://www.acclinate.com/
- LinkedIn https://www.linkedin.com/company/acclinateinc/
Related People
Del Smith, PhDFounder
United States -
Birmingham, Alabama
Dr. Del Smith uses his diverse background in healthcare, IT, higher education, and business to drive greater healthcare equity. He is the CEO and Cofounder of Acclinate, a company using sustained community engagement and AI to mobilize historically marginalized communities for greater equity in healthcare.
Prior to cofounding Acclinate, Del dedicated nearly fifteen years to higher education as a business professor and then Dean of a business school. His research on success factors of minority-owned businesses has been published in journals such as the Journal of Business Research and the Journal of Developmental Entrepreneurship.
Del is a U.S. Army veteran and holds a Ph.D. in Business from the University of Alabama.
Ethermed | $8,500,000 | (Apr 17, 2026)
Joyful Health | $17,000,000 | (Apr 17, 2026)
Worki.ai | $2,750,000 | (Apr 17, 2026)
Balerion AI | $6,000,000 | (Apr 17, 2026)
Beeline Medicines | $300,000,000 | (Apr 17, 2026)
Expo | $45,000,000 | (Apr 17, 2026)
Sepion Technologies | $10,000,000 | (Apr 17, 2026)
Lua AI (YC F25) | $5,800,000 | (Apr 17, 2026)
Nas.com | $27,000,000 | (Apr 17, 2026)
Resolv | $1,000,000 | (Apr 17, 2026)
Solidroad | $25,000,000 | (Apr 17, 2026)
Parasail | $32,000,000 | (Apr 16, 2026)